Georgia CORE aims to increase the skills and competencies of the cancer research workforce; raise awareness about the opportunities and benefits of clinical trials; incorporate the perspectives of patients and survivors into clinical cancer research; advocate for clinical trials financing, regulatory improvement and resource development; promote access to and enrollment in clinical trials; and stimulate dialogue and collaboration among multi-disciplinary cancer researchers.
Georgia CORE General Information Sheet
Includes an Overview of our Research Programs
2017 Organizational Overview and Strategic Priorities
2017 Overview and Impact
Annals of Surgical Oncology 2014, 10.1245/s10434-014-3921-1. Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative
Annals of Surgical Oncology 2014, 10.1245/s10434-014-3908-y. Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
Journal of Cancer Survivorship 2014, 10.1007/s11764-014-0391-1. The state of cancer survivorship programming in Commission on Cancer-accredited hospitals in Georgia
Clinical Breast Cancer 2013, Final Results from Phase II Trial of Neoadjuvant Docetaxel and Capecitabine Given Sequentially or Concurrently for HER2-Negative Breast Cancers
Journal of Oncology Practice2013, 10.1200/JOP.2013.000969. Shared Vision, Collective Impact, and Persistent Challenges: The First Decade of Georgia’s Oncology Research Network
The New England Journal of Medicine 2013, 10.1056/NEJMoal304369. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Georgia's Comprehensive Cancer Control Plan
Cancer is the second leading cause of death in Georgia. In 2013, an estimated 16,630 Georgians died of cancer; each day, more than 120 more Georgians are diagnosed with the disease.
The Georgia Department of Public Health and the Georgia Cancer Control Consortium envision a future Georgia that is free from cancer deaths and cancer-related health disparities. Accordingly, multi-faceted and layered approaches to cancer prevention and control are needed.
Georgia’s Comprehensive Cancer Control Plan offers a strategic vision to reduce the cancer burden in our state. The plan is a product of extensive input from stakeholders and describes Georgia’s eight priority areas for 2014-2019:
Cancer Risk Reduction: Tobacco and Obesity*
Vaccination for Human Papilloma Virus
Breast and Cervical Cancer Screening
Colorectal Cancer Screening
Lung Cancer Screening
Quality Cancer Diagnosis and Treatment
Access to Palliative Care and Survivorship
Patient Case Management and Care Coordination
*Please see the tobacco documents listed below for more resources.
The plan creates a path forward to reduce the number of cancer deaths in Georgia, maintain Georgia’s place as a national and international leader in cancer research, and improve the quality of life for those who have survived cancer. Efforts over the next five years will focus on linking public and private resources, increasing access to early detection and screening, and increasing the use of evidence-based screening guidelines and practice.
Statewide leadership, including the government, business, academic, and non-profit sectors, is essential to cancer prevention and control. The Georgia Department of Public Health, through and with the Georgia Cancer Control Consortium and its membership, will implement this plan and provide the statewide leadership necessary to bring together communities and resources for cancer prevention and control in Georgia.
To view Georgia’s Comprehensive Cancer Control Plan for 2014-2019, click here.
To view Georgia's Tobacco Control Stretegic Plan 2015-2020, click here.
Why Increase the Tax on Cigarettes and other Tobacco?: Raising It Is As Easy As $1.23 (American Cancer Society)
Tobacco Tax Increases General Fact Sheet (American Cancer Society)
Why Employers Care
Electronic Cigarettes Fact Sheet
To receive our electronic newsletter, please contact Elizabeth Fullerton.